Cargando…
Rituximab use for lymphoplasmacytic lymphoma during continuous renal replacement therapy
Rituximab safety and efficacy in patients with renal impairment have not been established, nor have the effects of hemodialysis on serum rituximab level. There are only a few published case reports assessing serum rituximab level pre- and postdialysis. No data have been published regarding the usage...
Autores principales: | Simões, Marco, Miranda, Marisa, Carda, José, Carmo, Anália, Martins, Paulo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação de Medicina Intensiva Brasileira -
AMIB
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649227/ https://www.ncbi.nlm.nih.gov/pubmed/31271628 http://dx.doi.org/10.5935/0103-507X.20190040 |
Ejemplares similares
-
A Unique Case of Renal Infiltration by Lymphoplasmacytic Lymphoma with Cast Nephropathy
por: Malhotra, Kiran P., et al.
Publicado: (2020) -
Ureteral amyloidosis in the context of lymphoplasmacytic lymphoma and systemic amyloidosis
por: Riaza Montes, María, et al.
Publicado: (2021) -
Amyloid myopathy as the presenting feature of lymphoplasmacytic lymphoma
por: Guduru, Zain, et al.
Publicado: (2017) -
Ibrutinib response in cutaneous transformed lymphoplasmacytic lymphoma
por: Lindholm, Kaleigh E., et al.
Publicado: (2021) -
Distal renal tubular acidosis in lymphoplasmacytic lymphoma Waldenström’s macroglobulinemia: a case report
por: Feringa, Harm HH, et al.
Publicado: (2009)